Related Experiment Videos
The evaluation of a multiple dosing protocol for the mouse bone-marrow micronucleus assay using benzidine and
J W Parton1, J E Beyers, M L Garriott
1Lilly Research Laboratories, Division of Eli Lilly and Company, Greenfield, IN 46140.
Mutation Research
|June 1, 1990
Summary
Benzidine exposure significantly increased micronucleated polychromatic erythrocytes (MPE) in mice bone marrow in a dose-dependent manner. 2,6-xylidine did not affect MPE frequency, indicating genotoxic potential differences.
Area of Science:
- Toxicology
- Genotoxicity Testing
- Chemical Safety
Background:
- Benzidine and 2,6-xylidine are aromatic amines with varying toxicological profiles.
- Assessing the genotoxic potential of industrial chemicals is crucial for public health and environmental safety.
- Micronucleus testing in bone marrow is a standard assay for detecting chromosomal damage.
Purpose of the Study:
- To evaluate the genotoxicity of benzidine and 2,6-xylidine in vivo.
- To determine the dose-response relationship for benzidine-induced micronuclei formation.
- To compare the genotoxic effects of benzidine and 2,6-xylidine in male ICR mice.
Main Methods:
- Male ICR mice were administered 1, 2, or 3 daily doses of benzidine or 2,6-xylidine.
- Dose levels were set at 10% and 50% of the median lethal dose for each chemical.
- Bone marrow was harvested 24 hours post-treatment and analyzed for micronucleated polychromatic erythrocytes (MPE).
Main Results:
- Benzidine caused a statistically significant, dose-related increase in MPE incidence (p < 0.001).
- 2,6-xylidine did not induce a significant increase in MPE frequency at any tested dose.
- The number of doses administered did not independently influence MPE incidence.
Conclusions:
- Benzidine exhibits clear genotoxic activity in vivo, as evidenced by increased MPE.
- 2,6-xylidine does not appear to be genotoxic under the conditions of this study.
- The study highlights the differential genotoxic potential of structurally related aromatic amines.